Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

Annick Desjardins,James E. Herndon,Frances McSherry,Arliene Ravelo,Eric Lipp,Patrick Healy,Katherine B. Peters,John H. Sampson,Dina Randazzo,Nicolas Sommer,Allan H. Friedman,Henry S. Friedman

Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

2019

Annick Desjardins
James E. Herndon
Frances McSherry
Arliene Ravelo
Eric Lipp
Patrick Healy
Katherine B. Peters
John H. Sampson
Dina Randazzo
Nicolas Sommer
Allan H. Friedman
Henry S. Friedman

Background and aims This retrospective review of patients with recurrent glioblastoma treated at the Preston Robert Tisch Brain Tumor Center investigated treatment patterns, survival, and safety with bevacizumab in a real‐world setting.

Keywords:

Clinical Practice
Bevacizumab
Glioblastoma
Oncology
Internal medicine
Medicine
Clinical trial
Proportional hazards model
Cohort
Irinotecan
Salvage therapy
Adverse effect
Carboplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations